Physician profile
Michael Ryan Wolf
NPI 1457973729
$9,362.17
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $95.74 · 2021: $2,601 · 2022: $3,426 · 2023: $2,170 · 2024: $1,070.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,871 · Travel and Lodging: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,871.23 |
| Travel and Lodging | $368.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $3,600.00 | 2021-2022 | |
| Stryker Corporation | $3,198.29 | 2020-2024 | Augment Injectable, Easyfuse, Prostep |
| Treace Medical Concepts, INC. | $532.49 | 2021-2024 | |
| Osteomed LLC | $329.75 | 2022 | |
| Acumed LLC | $306.99 | 2023-2024 | Osteomed, Acumed |
| Smith+Nephew, INC. | $190.29 | 2021-2022 | |
| Next Science LLC | $176.39 | 2023 | Surgx, Blastx, Xperience |
| Amgen INC. | $161.04 | 2024 | Krystexxa |
| Imperative Care, INC | $149.73 | 2023 | Prodigy Catheter |
| Integra Lifesciences Corporation | $95.04 | 2022 | |
| Biotissue Holdings INC. | $92.12 | 2023 | |
| Acera Surgical, INC. | $89.98 | 2022-2024 | Restrata Wound Matrix |
| Sanara Medtech INC. | $89.95 | 2024 | Celleraterx, Biasurge |
| Depuy Synthes Sales INC. | $64.07 | 2022 | |
| Paratek Pharmaceuticals, INC. | $53.98 | 2024 | Nuzyra |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $44.26 | 2024 | Novosorb Btm |
| Mimedx Group, INC. | $42.61 | 2024 | |
| Nevro Corp. | $21.85 | 2024 | Senza |
| Eagle Pharmaceuticals, INC. | $20.28 | 2023 | |
| Averitas Pharma INC. | $19.84 | 2024 | Qutenza |
| Kci USA, INC. | $18.57 | 2023 | Activ.A.C. |
| Innocoll Pharmaceuticals Limited | $18.45 | 2022 | |
| Solventum Corporation | $16.86 | 2024 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Abbvie INC. | $14.69 | 2023 | Dalvance |
| Paragon 28, INC. | $14.65 | 2024 | Baby Gorilla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.